ChemoTech reports Q1 2026 financials
Net sales reach 2,798 KSEK, up from 2,472 KSEK. Strongest Q1 in history with progress in Animal Care and India approval.
See the latest news and media coverage for ChemoTech. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of tumour treatment technology for humans and animals
chemotech.seLast updated
In short: ChemoTech achieved record Q1 2026 sales, advanced its clinical trials in India, and proposed a strategic name change and reorganization.
Net sales reach 2,798 KSEK, up from 2,472 KSEK. Strongest Q1 in history with progress in Animal Care and India approval.
Net sales reach 12.3 MSEK, up from 6.6 MSEK; loss narrows to -8.1 MSEK. Animal Care drives growth with U.S. order and strong sales.
Net sales 3,324 KSEK (1,499), loss -1,267 KSEK. Animal Care reaches record sales and 3,000 treatments.
Procedures target head and neck cancer in Indian trial with Mohan Frick's participation.
The report is attached to this press release and can also be downloaded from the company's website January - March 2026 Net sales amounted to...
NOT FOR DISCLOSURE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN...
At close: July 25 at 8:21:31 a.m. GMT+2...
This financing round was specifically structured as a win-win for both existing shareholders and the new investors. The proceeds will support ChemoTech's continued commercial growth...
Track ChemoTech and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.